Authors

• Reem Karmali (ORCID: https://orcid.org/0000-0003-0984-4376)
• Thomas A. Ollila (ORCID: https://orcid.org/0000-0003-0102-6491)
• Geoffrey Shouse (ORCID: https://orcid.org/0000-0002-7917-5713)
• Praveen Ramakrishnan Geethakumari (ORCID: https://orcid.org/0000-0002-7694-4644)
• Stefan Klaus Barta (ORCID: https://orcid.org/0000-0002-3280-5271)
• Pallawi Torka (ORCID: https://orcid.org/0000-0002-1681-5883)
• Dai Chihara (ORCID: https://orcid.org/0000-0002-1153-2294)
• Natalie Sophia Grover (ORCID: https://orcid.org/0000-0002-1346-3157)
• Nancy L. Bartlett (ORCID: https://orcid.org/0000-0001-8470-394X)
• Narendranath Epperla (ORCID: https://orcid.org/0000-0002-8216-3457)
• Colin Thomas
• A. Olszewski (ORCID: https://orcid.org/0000-0003-3368-5475)

Institutions

• Northwestern University (US)
• University of North Carolina at Chapel Hill (US)
• Roswell Park Comprehensive Cancer Center (US)
• City Of Hope National Medical Center (US)
• Memorial Sloan Kettering Cancer Center (US)
• The University of Texas MD Anderson Cancer Center (US)
• Thomas Jefferson University (US)
• Washington University in St. Louis (US)
• University of Utah (US)
• Brown University (US)
• Huntsman Cancer Institute (US)
• Southwestern Medical Center (US)
• Northwestern University (PH)
• Northwestern Medicine (US)
• Southwestern Medical Center (US)
• University of Pennsylvania (US)
• The University of Texas Southwestern Medical Center (US)

Publication Details

Journal

Haematologica

Published

2025-11-27

DOI

https://doi.org/10.3324/haematol.2025.288946

Primary Topic

Lymphoma Diagnosis and Treatment

Type

article

Field-Weighted Citation Impact

0.00

Funders

• Eli Lilly and Company
• Pfizer
• Gilead Sciences
• BeiGene
• National Institutes of Health
• Genentech
• Pharmacyclics